Infection

(1347019) The Power of the Microbiome: Its Role in the Development, Maintenance, and Outcomes of Sepsis

(1347008-01) Epidemiology of Fungal Disease in the Critically Ill

(1347019-01) Microbiome and Critical Illness: Impacts on Human Health

(1347008-02) Fungus Among Us: New Diagnostic Methods and Identification of Fungal Disease

(1347019-02) A Fad or a Competent Therapy: Sepsis and the Microbiome

(1347008-03) Something Old, Something New, Should We Just Go to Isavu?

(1347019-03) Inflammation and the Microbiome: Age-Related Outcomes in the Geriatric Septic Patient

(545085) Clinical Evidence for Host-Directed Therapeutics

(545085-01) Repurposing Host-Directed Therapeutics for COVID-19

(545085-02) The Role of Platform Trials

(545085-03) The Use of Clinical Data to Inform and Identify the Potential New Value of Existing HDTs

(545085-04) Clinical Evidence Necessary to Support Clinical Guidelines for the Use of HDTs

(545085-05) Clinical Unmet Need for HDTs

(545085-06) BARDA’s Interest in HDTs and Funding Opportunities

(545085-07) Panel Discussion